India’s single-specialty hospital market set for rapid 22% annual growth through 2030

58

TL;DR

India’s single-specialty hospital market is projected to grow at a 22% compound annual growth rate (CAGR) — reaching about $12.3 billion by 2030, up from approximately $4.4 billion in 2025. The trend reflects a shift from large multi-specialty hospitals toward focused, asset-light specialty care models that deliver strong clinical outcomes and financial returns.  

Article

India’s healthcare provider landscape is evolving rapidly, with the single-specialty hospital market emerging as one of its fastest-growing segments. A recent report by Bessemer Venture Partners projects that the market’s value will expand from roughly $4.4 billion in 2025 to about $12.3 billion by 2030, registering a robust 22% annual growth rate — nearly double the pace of the broader provider sector. 

Nithin Kaimal, Partner, Bessemer Venture Partners, India – “As this market races toward $12 billion, we expect the next generation of iconic Indian healthcare companies will be built one specialty at a time.” 

The report highlights that single-specialty providers — facilities focused on specific clinical areas such as eye care, oncology and dental care — benefit from attractive financial profiles, including shorter payback periods (12–18 months) and sustainable EBITDA margins above 20%.  

Industry observers say the healthcare ecosystem is shifting away from capital-intensive “mega-hospitals” toward purpose-built specialty centers rooted in repeatable protocols and concentrated clinical expertise. These models make use of leaner, hub-and-spoke expansion frameworks, enabling rapid replication in both Tier-1 and Tier-2 cities to serve high-volume, standardisable care needs.  

The relatively unbranded nature of the specialty sector also offers opportunities for category leaders to emerge, potentially becoming attractive candidates for initial public offerings (IPOs) or acquisitions by established healthcare conglomerates.  

According to Bessemer, the winners in this space will be those that combine clinical depth with disciplined scaling, expanding access while generating long-term value. India’s strong share (26%) of healthcare private equity deal volume in the Asia-Pacific region further underscores investor confidence in the segment.